• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives Biphenylcarbonitriles

Research Brief on 3-Cyano-5-(2-methoxy-5-methylphenyl)phenol (CAS: 1261924-71-3): Recent Advances and Applications

3-Cyano-5-(2-methoxy-5-methylphenyl)phenol (CAS: 1261924-71-3) is a chemically synthesized compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential therapeutic applications. Recent studies have explored its role as a key intermediate in the synthesis of novel bioactive molecules, particularly in the development of kinase inhibitors and anti-inflammatory agents. This research brief aims to summarize the latest findings related to this compound, highlighting its structural properties, biological activities, and potential applications in drug discovery.

Structural analysis of 3-Cyano-5-(2-methoxy-5-methylphenyl)phenol reveals a phenol core substituted with a cyano group at the 3-position and a 2-methoxy-5-methylphenyl moiety at the 5-position. This unique arrangement confers specific electronic and steric properties that make it an attractive scaffold for medicinal chemistry. Recent computational studies have demonstrated its ability to interact with various biological targets, including protein kinases and nuclear receptors, suggesting its versatility in drug design.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers investigated the compound's potential as a selective inhibitor of the JAK-STAT signaling pathway, which is implicated in inflammatory and autoimmune diseases. The study reported that derivatives of 3-Cyano-5-(2-methoxy-5-methylphenyl)phenol exhibited potent inhibitory activity against JAK2 and JAK3 kinases, with IC50 values in the nanomolar range. These findings underscore its potential as a lead compound for developing new anti-inflammatory therapies.

Another significant application of 3-Cyano-5-(2-methoxy-5-methylphenyl)phenol lies in its role as a fluorescent probe. A recent publication in Analytical Chemistry highlighted its use in detecting reactive oxygen species (ROS) in cellular environments. The compound's cyano and phenol groups enable it to undergo specific redox reactions, resulting in measurable fluorescence changes. This property has been leveraged to develop sensitive assays for oxidative stress, which is relevant in studying neurodegenerative diseases and cancer.

Despite these promising developments, challenges remain in optimizing the pharmacokinetic properties of 3-Cyano-5-(2-methoxy-5-methylphenyl)phenol derivatives. A 2024 preclinical study noted issues related to metabolic stability and bioavailability, which are critical for advancing these compounds into clinical trials. Researchers are currently exploring structural modifications, such as the introduction of heterocyclic rings or prodrug strategies, to address these limitations.

In conclusion, 3-Cyano-5-(2-methoxy-5-methylphenyl)phenol (CAS: 1261924-71-3) represents a versatile and promising scaffold in chemical biology and drug discovery. Its applications span from kinase inhibition to fluorescent probing, reflecting its broad utility. Future research should focus on optimizing its drug-like properties and expanding its therapeutic potential. This compound is poised to play a significant role in the development of next-generation therapeutics, particularly in areas such as inflammation, oncology, and neurodegenerative diseases.

• 1261952-63-9(2-Cyano-5-(4-methoxy-3-methylphenyl)phenol)
• 1261975-66-9(4-(2,5-dimethoxyphenyl)-2-hydroxybenzonitrile)
• 1261894-75-0(3-Cyano-5-(4-methoxy-3-methylphenyl)phenol)
• 113547-30-1(2'-Methoxy-[1,1'-biphenyl]-4-carbonitrile)
• 206867-52-9(2',5'-Dimethoxy-[1,1':4',1''-terphenyl]-4,4''-dicarbonitrile)
• 1262967-17-8(2',4',6'-Trimethoxy-[1,1'-biphenyl]-4-carbonitrile)
• 118693-49-5(2'-Hydroxy-5'-methoxy-[1,1'-biphenyl]-4-carbonitrile)
• 1261924-88-2(3-Cyano-5-(2,5-dimethoxyphenyl)phenol)
• 1261919-09-8(2-Cyano-4-(2-methoxy-5-methylphenyl)phenol)
• 1261931-70-7(2-Cyano-5-(2-methoxyphenyl)phenol)